Evaluation of safety and tolerability of a single injection of NOVA63035 "Corticosteroid"
administered at one of four doses in patients with diabetic macular edema (DME) secondary to
- M & F 18 years and older
- Diagnosed with diabetes mellitus and presenting diabetic retinopathy
- History of current ocular hypertension or glaucoma in either eye defined
- Any significant ocular disease (other than diabetic retinopathy)